MyFinsight
Home
Blog
About
HARROW, INC. (HROWM)
HARROW, INC. (HROWM)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
$16,378K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from new debt, net of c...
Loss on extinguishment of debt
Stock-based compensation
Others
Negative Cash Flow Breakdown
Repayment of notes payable, incl...
Payment of payroll taxes upon ve...
Accounts payable, accrued expens...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2025-09-30
2025-06-30
Amortization of operating lease right-of-use assets
-
399
Investment loss from investment in eton pharmaceuticals
-
0
Net loss
1,020
-12,785
Depreciation and amortization of property, plant and equipment and software development costs
490
961
Amortization of intangible assets
4,224
8,452
Non-cash lease expense
583
-
Deferred income tax
-
0
Provision for (recovery of) credit losses
208
340
Amortization of debt issuance costs and debt discount
1,128
2,564
Loss on extinguishment of debt
-7,750
-
Stock-based compensation
3,271
5,431
Accounts receivable
-1,014
-37,211
Inventories
1,282
850
Prepaid expenses and other current assets
1,327
-3,776
Accounts payable, accrued expenses, accrued rebates and copay assistance
-3,040
-24,009
Accrued payroll and related liabilities
2,694
-2,672
Deferred revenue and customer deposits
254
47
Net cash provided by (used in) operating activities
16,588
18,865
Investment in patent and trademark assets
-147
169
Net proceeds on sale of investment in eton pharmaceuticals
-
0
Purchase of product rights and related patents
162
-
Purchases of property, plant and equipment
210
336
Net cash (used in) provided by investing activities
-225
-505
Proceeds from new debt, net of costs
244,375
-
Payment of debt issuance costs
1,581
0
Repayment of notes payable, including exit costs
230,901
-
Payment of payroll taxes upon vesting of psus, rsus and exercise of stock options
7,091
12,769
Proceeds from exercise of stock options
162
125
Net cash used in financing activities
4,964
-12,644
Net change in cash and cash equivalents
21,327
5,716
Cash and cash equivalents at beginning of period
47,247
-
Cash and cash equivalents at end of period
74,290
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Loss on
extinguishment of debt
-$7,750K
Amortization of intangible
assets
$4,224K
Stock-based compensation
$3,271K
Accrued payroll and
related liabilities
$2,694K
Proceeds from new debt,
net of costs
$244,375K
Amortization of debt issuance
costs and debt...
$1,128K
Net loss
$1,020K
Accounts receivable
-$1,014K
Non-cash lease expense
$583K
Depreciation and
amortization of property,...
$490K
Deferred revenue and
customer deposits
$254K
Proceeds from exercise of
stock options
$162K
Net cash provided by
(used in) operating...
$16,588K
Net cash used in
financing activities
$4,964K
Canceled cashflow
$5,649K
Canceled cashflow
$239,573K
Net change in cash
and cash...
$21,327K
Canceled cashflow
$225K
Accounts payable,
accrued expenses,...
-$3,040K
Prepaid expenses and
other current assets
$1,327K
Inventories
$1,282K
Repayment of notes
payable, including exit...
$230,901K
Payment of payroll taxes
upon vesting of psus,...
$7,091K
Payment of debt issuance
costs
$1,581K
Investment in patent and
trademark assets
-$147K
Net cash (used in)
provided by investing...
-$225K
Canceled cashflow
$147K
Purchases of property,
plant and equipment
$210K
Purchase of product
rights and related...
$162K
Buy us a coffee